Welcome to Ambrichor biobank of plasma and tissue samples
Enabling research in cancer detection
Welcome to Ambrichor biobank of plasma and tissue samples
Enabling research in cancer detection
Our Services
Ambrichor provides access to biological samples for the development and regulatory validation of blood-based cancer tests.
Ambrichor collects plasma samples from a high risk, asymptomatic cohort of individuals and cancer patients. Our first indication is lung cancer, in which our region has the highest incidence worldwide. The sample collection fulfils the most rigorous pre-analytical requirements of cell free nucleic acid, exosome or epitope analysis. It also fulfils the regulatory, quality control and documentation requirements of clinical validation for registration studies submitted to Notified Bodies or US Food and Drug Administration.
Management
Attila Berces
Attila Berces
Attila Berces
Ph.D. Co-founder, Executive Chairman
Attila is the founder and Chairman of Omixon, a leader transplantation genetics. He raised or help raise over $10M VC financing and is helping various start-up companies. He has executive and management experience in AstraZeneca and Novartis. As a researcher he published over 50 publications and was cited over 1700 times.
Zoltan Szabo
Attila Berces
Attila Berces
MD, MBA Co-founder, Chief Medical Officer
Zoltan is an expert in international tissue regulation, technology transfer and distribution. He is a former deputy director general of Hungarian Blood and Transplant.
.png/:/rs=w:365,h:365,cg:true,m/cr=w:365,h:365)
Alex Drijver
A. Marcell Szasz, MD, PhD
A. Marcell Szasz, MD, PhD
Co-founder, CBO
Alex is a business development, contracting and financial expert. He has taken a number of drug discovery and technology companies through their early growth phase and also on to exit as CEO and CFO.
A. Marcell Szasz, MD, PhD
A. Marcell Szasz, MD, PhD
A. Marcell Szasz, MD, PhD
Co-founder, Chief Pathologis
Marcell is pathologist with over 60 peer-reviewed publications. He is Head of Research at the Oncology Center at Semmelweis University in Budapest.
Advisory Board
Dr. Laszlo Takacs
Dr. Laszlo Takacs
Dr. Laszlo Takacs
MD, PhD Co-founder, Head of Clinical and Scientific Advisory Board
Laszlo has developed two early stage lung caner tests, one acquired by Roche, one co-marketed by Randox. As a co-founder of Biosystems International he raised over $20M in capital and grants. Laszlo has conducted early stage lung cancer clinical studies of relevance to Ambrichor.
.png/:/cr=t:13.07%25,l:4.68%25,w:84.75%25,h:83.3%25/rs=w:365,h:365,cg:true,m)
Janos Kosa
Dr. Laszlo Takacs
Dr. Laszlo Takacs
Ph.D Co-founder, Principle Investigator
Janos has co-founded and is managing director of Pentacore Labs, a next-generation sequencing-based genetic service laboratory, recently acquired by Servier. Janos has carried out a prospective thyroid cancer genetics study on high risk cohort.
Colleagues
Renáta Kun
Gabriella Polyák
Gabriella Polyák
Laboratory Manager
Gabriella Polyák
Gabriella Polyák
Gabriella Polyák
Office Manager
Tünde Tóth
Gabriella Polyák
Tünde Tóth
Marketing Manager
